Speaker

Mayo Pujols

Chief Technology Officer, Kyverna Therapeutics

Mayo Pujols, Chief Technology Officer at Kyverna Therapeutics, spoke at 3rd Raw Materials for Cell & Gene Therapy Summit (San Diego, United States of America, 26–28 Oct 2026) in the session “Planning Material Grade Transitions Early to Avoid Late-Stage Requalification & Delayed Timelines”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Past appearances

3rd Raw Materials for Cell & Gene Therapy Summit
26–28 Oct 2026San Diego, United States of America
- WorkshopPlanning Material Grade Transitions Early to Avoid Late-Stage Requalification & Delayed TimelinesWith Alison Burkart, Shawn Wang

More speakers at 3rd Raw Materials for Cell & Gene Therapy Summit

James Adams
Chief Technical Officer, Tr1x therapeutics
Daniel Anaya
Associate Director, MS&T, Ray Therapeutics
Lili Belcastro
Associate Director, Raw Materials, Drug Product Process Development, Bristol Myers Squibb
Benjamin Cho
Technical Development Scientist II, Genentech
Ben Clarke
Senior Scientist, Global Biologics, U.S. Pharmacopeia
Basak Clements
Independent Raw Materials Expert & USP CGT Expert Committee Member, Independent Expert

See all 16 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Mayo Pujols, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].